Breathing Easy: Royal Sense’s Nebulizers Win FDA’s Stamp of Approval

Royal Sense Limited, a top Indian supplier of medical and surgical devices, has made notable progress with the US Food and Drug Administration (FDA) providing approval for its line of nebulizer products. The news, released on April 15, 2025, represents a breakthrough for the company in attempting to establish further presence within the global health care market.

 

The FDA endorsement reflects the quality and safety of Royal Sense's nebulizers for use in hospital, clinic, and homecare respiratory therapies. Nebulizers are pivotal in administering medication into the lungs, especially for patients who have chronic respiratory diseases like asthma and COPD. This regulatory green light not only acknowledges Royal Sense's production standards but also paves the way to the potentially lucrative US medical device market, which is renowned for its strict compliance regulations.

 

Royal Sense enjoys a wide presence in India, supplying products to key government organizations and hospitals in multiple states. With this FDA clearance, the company is set to improve its global reputation and aid better respiratory care on the planet.

 

Sources: MarketScreener